MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KUROSAWA, A.
Right arrow Articles by COSTA, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KUROSAWA, A.
Right arrow Articles by COSTA, E.

Molecular Pharmacology, Vol 15, 115-130, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Nuclear Translocation of Cyclic AMP-Dependent Protein Kinase Subunits During the Transsynaptic Activation of Gene Expression in Rat Adrenal Medulla

ATSUSHI KUROSAWA 1, ALESSANDRO GUIDOTTI 1, and ERMINIO COSTA 1

1 Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D. C. 20032

In rat adrenal medulla gene expression can be activated by transsynaptic stimulation of nicotinic receptors via an increase of the adenosine 3',5' monophosphate content (cyclic AMP). This increase activates the cyclic AMP-dependent ATP: protein phosphotransferase (protein kinase) of adrenal medulla. Type I and II cyclic AMP-dependent protein kinases are present in the adrenal medulla cytosol; both enzymes were activated and dissociated into regulatory and catalytic subunits following the increase of medullary cyclic AMP content elicited transsynaptically. However only the cytosol content of Type I cyclic AMP-dependent protein kinase but not that of Type II enzymes decreases for several hours following persistent activation of nicotinic receptors. This decrease was associated with the appearance of catalytic subunits of cyclic AMP-dependent protein kinase in nuclei. The phosphorylation of endogenous nuclear protein was increased after the redistribution of the catalytic subunits of cyclic AMP-dependent protein kinase elicited by the persistent stimulation of nicotinic receptors. A similar increase of nuclear protein phosphorylation was elicited also "in vitro" by incubating nuclei of adrenal medulla with cyclic AMP and cyclic AMP-dependent Type I protein kinase; in contrast, the incubation of these nuclei with Type II protein kinase failed to increase the phosphorylation of nuclear proteins. For comparison, the fate of catalytic subunits of cyclic AMP-dependent protein kinase of pineal gland cytosol was studied following a sustained transsynaptic activation of protein kinase. Only Type II cyclic AMP-dependent protein kinase is present in pineal cytosol. This enzyme was activated and dissociated following the increase of cyclic AMP content elicited by isoproterenol, but its catalytic subunits failed to translocate into the pineal cell nuclei suggesting that translocation into nuclei is not a generalized property of cyclic AMP-dependent protein kinase.

Submitted on January 26, 1978
Accepted on September 25, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics